What Insurance Covers Zepbound, and What to Do When It Does Not

Zepbound (tirzepatide) is a GLP-1 receptor agonist approved by the FDA for chronic weight management. Insurance coverage for Zepbound varies widely by plan, employer and state.

Insurance Coverage for Zepbound

Major insurers including Anthem, UnitedHealthcare, Aetna and Cigna have gradually expanded Zepbound coverage since its 2023 approval, though many plans still require prior authorisation. Medicare and Medicaid coverage remains limited and varies by state.

Coverage typically requires:

• A BMI of 27 or higher with at least one weight-related comorbidity, or a BMI of 30 or higher
• Documentation of failed weight loss attempts with diet and exercise
• Prior authorisation from your plan

When Insurance Does Not Cover Zepbound

If your plan denies coverage, you have several options:

Patient assistance programmes: Eli Lilly offers the Lilly Insulin Value Programme, which provides free or discounted Zepbound to uninsured or underinsured patients.

GLP-1 discount programmes: Services like GoodRx and SingleCare can reduce out-of-pocket costs, though prices remain high without insurance.

Switching plans: If you have employer coverage, check whether other available plans offer Zepbound coverage during open enrollment.

Telehealth providers: Some telehealth services specialising in weight management may offer lower-cost alternatives or direct-to-patient pricing.

Next Steps

Contact your insurance company to request a coverage determination for Zepbound. Ask specifically about prior authorisation requirements and any step therapy protocols. If denied, request a peer-to-peer review with your doctor.

https://ratedbypatients.com/articles/what-insurance-covers-zepbound-and-what-to-do-when-it-does-not/